Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Division of Medicine, Akershus University Hospital and University of Oslo, Oslo, Norway.
JAMA Cardiol. 2022 Jun 1;7(6):623-631. doi: 10.1001/jamacardio.2022.0680.
Sex- and race-based differences in N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations are poorly understood. Clinical decisions are often informed by absolute-as opposed to relative-risk, but absolute risk of incident heart failure (HF) associated with NT-proBNP concentration across these important demographic categories is unclear.
To determine whether physiologic determinants of NT-proBNP concentrations account for sex and race differences, and to more uniformly predict HF risk using NT-proBNP in these demographic subgroups.
DESIGN, SETTING, AND PARTICIPANTS: In the longitudinal Atherosclerosis Risk in Communities epidemiologic prospective community-based cohort study, the association of NT-proBNP concentration with relative and absolute risk of HF by sex- and race-based categories was assessed at study visit 2 (1990-1992) and study visit 5 (2011-2013) using Cox and Poisson regression. These data were analyzed from June 2018 to October 2021. The contribution of clinical, anthropometric, echocardiographic, and laboratory parameters to sex- and race-based differences in NT-proBNP concentration was assessed at visit 5 using linear regression. Participants included were free of HF in midlife (visit 2; a total of 12 750 participants) and late life (visit 5; a total of 5191 participants).
NT-proBNP concentration.
Incident HF or death.
Among the 5191 HF-free participants at visit 5, the mean (SD) age was 76.0 (5.2) years, 2104 (41%) were male, 1043 (20%) were Black, and the median (IQR) NT-proBNP concentration was 124 (64-239) pg/. In both midlife and late life, NT-proBNP concentration was lowest in Black men (median [IQR] concentration: visit 2, 30 [14-67] pg/mL; visit 5, 74 [34-153] pg/mL) and highest in White women (median [IQR] concentration: visit 2, 70 [42-111] pg/mL; visit, 5, 154 [82-268] pg/mL). Sex and race differences in NT-proBNP concentration persisted after accounting for age, income, education, area deprivation index, cardiovascular diseases, left ventricular structure (LV), LV function, LV wall stress, weight and fat mass, and estimated glomerular filtration rate. Substantial differences in the absolute risk of incident HF or death existed across the sex- and race-based categories at any NT-proBNP concentration (eg, 7-fold [rate ratio, 6.7; 95% CI, 4.6-9.9] and 3-fold [rate ratio, 2.7; 95% CI, 1.7-4.1] difference at visit 2 and visit 5, respectively, at guideline-recommended thresholds) with higher risk consistently observed among Black men and lower risk in White women. Results were replicated in a cohort of participants from the Cardiovascular Health Study.
In this study, sex- and race-based differences in NT-proBNP persisted after accounting for known physiologic determinants. Absolute risk associated with a given value of NT-proBNP varied substantially by sex and race. Consideration of NT-proBNP values in the context of sex and race allows for more uniform prediction of absolute risk across important demographic subgroups.
N-末端 B 型利钠肽前体(NT-proBNP)浓度的性别和种族差异了解甚少。临床决策通常是基于绝对风险,而不是相对风险,但与 NT-proBNP 浓度相关的心力衰竭(HF)事件的绝对风险在这些重要的人口统计学类别中尚不清楚。
确定 NT-proBNP 浓度的生理决定因素是否解释了性别和种族差异,并使用 NT-proBNP 更均匀地预测这些人口统计学亚组的 HF 风险。
设计、地点和参与者:在社区队列前瞻性社区为基础的 Atherosclerosis Risk in Communities 流行病学研究中,在研究访问 2(1990-1992 年)和研究访问 5(2011-2013 年)中,使用 Cox 和泊松回归评估 NT-proBNP 浓度与性别和种族分类的 HF 相对和绝对风险的相关性。这些数据是在 2018 年 6 月至 2021 年 10 月之间进行分析的。使用线性回归评估临床、人体测量、超声心动图和实验室参数对 NT-proBNP 浓度的性别和种族差异的贡献。参与者包括在中年(访问 2;共 12750 名参与者)和晚年(访问 5;共 5191 名参与者)无 HF 的人群。
NT-proBNP 浓度。
HF 或死亡的发生率。
在 5191 名 HF 无患者中,中位(SD)年龄为 76.0(5.2)岁,2104 名(41%)为男性,1043 名(20%)为黑人,中位(IQR)NT-proBNP 浓度为 124(64-239)pg/ml。在中年和晚年,黑人男性的 NT-proBNP 浓度最低(中位数[IQR]浓度:访问 2,30[14-67]pg/ml;访问 5,74[34-153]pg/ml),白人女性的浓度最高(中位数[IQR]浓度:访问 2,70[42-111]pg/ml;访问 5,154[82-268]pg/ml)。在考虑年龄、收入、教育程度、区域贫困指数、心血管疾病、左心室结构(LV)、LV 功能、LV 壁应力、体重和脂肪量以及估计肾小球滤过率后,NT-proBNP 浓度的性别和种族差异仍然存在。在任何 NT-proBNP 浓度下,HF 或死亡发生率的绝对风险在性别和种族分类中都存在显著差异(例如,在访问 2 和访问 5 时,分别为 7 倍[率比,6.7;95%CI,4.6-9.9]和 3 倍[率比,2.7;95%CI,1.7-4.1]),黑人男性的风险更高,白人女性的风险更低。在心血管健康研究的参与者队列中得到了复制。
在这项研究中,在考虑到已知生理决定因素后,NT-proBNP 的性别和种族差异仍然存在。与特定 NT-proBNP 值相关的绝对风险在性别和种族之间有很大差异。考虑 NT-proBNP 值在性别和种族背景下,可以更均匀地预测重要人口统计学亚组的绝对风险。